Revolutionizing Pharma: The Strategic Guide to AI Deployment
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Platinum-Resistant Primary Peritoneal Carcinoma
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB00062
Albumin human
1
Active Not Recruiting
1
DB17450
Albumin-stabilized nanoparticle (130 nm)
1
Active Not Recruiting
1
DB00041
Aldesleukin
1
Active Not Recruiting
1
DB00112
Bevacizumab
1
Active Not Recruiting
1
DB00997
Doxorubicin
1
Enrolling by Invitation
1
DB00997
Doxorubicin
1
Terminated
1
DB00441
Gemcitabine
1
Active Not Recruiting
1
DB06186
Ipilimumab
1
Active Not Recruiting
1
DB00888
Mechlorethamine
1
Active Not Recruiting
1
DB16235
Mirvetuximab
1
Enrolling by Invitation
1
DB12489
Mirvetuximab soravtansine
1
Enrolling by Invitation
1
DB09035
Nivolumab
1
Active Not Recruiting
1
DB09074
Olaparib
1
Completed
1
DB06306
Onalespib
1
Completed
1
DB17237
PHI-101
1
Recruiting
1
DB01229
Paclitaxel
1
Active Not Recruiting
1
DB09037
Pembrolizumab
1
Recruiting
1
DB09037
Pembrolizumab
1
Terminated
1
DB17519
TILT-123
1
Recruiting
1
DB11595
Atezolizumab
1 / 2
Active Not Recruiting
1
DB17522
Batiraxcept
1 / 2
Active Not Recruiting
1
DB11059
Carboxymethylcellulose
1 / 2
Active Not Recruiting
1
DB00531
Cyclophosphamide
1 / 2
Active Not Recruiting
1
DB01262
Decitabine
1 / 2
Active Not Recruiting
1
DB11714
Durvalumab
1 / 2
Active Not Recruiting
1
DB11918
Guadecitabine
1 / 2
Active Not Recruiting
1
DB17293
Hiltonol
1 / 2
Active Not Recruiting
1
DB17107
Lifileucel
1 / 2
Active Not Recruiting
1
DB00123
Lysine
1 / 2
Active Not Recruiting
1
DB11793
Niraparib
1 / 2
Not Yet Recruiting
1
DB15185
Rasdegafusp alfa
1 / 2
Active Not Recruiting
1
DB11135
Selenium
1 / 2
Not Yet Recruiting
1
DB14809
Anetumab ravtansine
2
Active Not Recruiting
1
DB11595
Atezolizumab
2
Recruiting
1
DB11105
Benzalkonium
2
Recruiting
1
DB00112
Bevacizumab
2
Active Not Recruiting
2
DB00112
Bevacizumab
2
Completed
1
DB14844
Dordaviprone
2
Recruiting
1
DB00997
Doxorubicin
2
Active Not Recruiting
1
DB11714
Durvalumab
2
Recruiting
1
DB00441
Gemcitabine
2
Active Not Recruiting
1
DB00762
Irinotecan
2
Completed
1
DB09078
Lenvatinib
2
Active Not Recruiting
1
DB10315
Measles virus vaccine live attenuated
2
Active Not Recruiting
1
DB01229
Paclitaxel
2
Active Not Recruiting
3
DB01229
Paclitaxel
2
Recruiting
1
DB09037
Pembrolizumab
2
Active Not Recruiting
1
DB05482
SN-38
2
Recruiting
1
DB11119
Sodium iodide
2
Active Not Recruiting
1
DB00759
Tetracycline
2
Active Not Recruiting
1
DB01030
Topotecan
2
Active Not Recruiting
1
DB11771
Tremelimumab
2
Recruiting
1
DB08828
Vismodegib
2
Recruiting
1